CPR‑CYC‑202
Inflammatory Diseases
PreclinicalActive
Key Facts
About Chugai Pharmabody Research
CPR pioneers antibody and cyclic peptide drug discovery to address unmet medical needs worldwide.
View full company profileTherapeutic Areas
Other Inflammatory Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| Amilo-5MER | Galmed Pharmaceuticals | Preclinical |
| Biosimilar to Simponi® (golimumab) | Teva | Under Regulatory Review |
| Fbxo3 Inhibitor Program | Koutif Therapeutics | Pre-clinical |
| SRB1 | SunRock Biopharma | Discovery |
| Follow-on Compounds | Abivax | Research |
| CDX-622 | Celldex Therapeutics | Phase 1 |
| Avdoralimab (IPH5401) | Innate Pharma | Phase 2 |
| Izicopan (IFX-4) | InflaRx | Preclinical |
| IFX002 | InflaRx | Preclinical |